Navigation Links
Balzan Foundation announces 2007 winners
Date:9/5/2007

The names of the 2007 Balzan Prize winners were announced today in a public event:

  • Rosalyn Higgins (UK), President of the International Court of Justice, The Hague, for international law after 1945
  • Michel Zink (France), Coll ge de France, Paris, for European literature (1000-1500)
  • Bruce Beutler (USA) and Jules Hoffmann (France), The Scripps Research Institute, La Jolla, California and Acadmie des Sciences, Paris, for innate immunity
  • Sumio Iijima (Japan), Meijo University, Nagoya, for nanoscience

The Balzan Prize for Humanity, Peace and Brotherhood among Peoples was awarded to Karlheinz B hm, founder of the humanitarian organization Menschen fr Menschen (Humans for Humans).

The profiles of the winners and the motivations of the awards were presented by several members of Balzan's General Prize Committee.

Luzius Wildhaber (former President of the European Court of Human Rights, Professor Emeritus of International, Constitutional and Comparative Law at the University of Basle) justified the assignment of the Balzan Prize for International Law since 1945 to Rosalyn Higgins as follows: "for her outstanding contributions to the development of international law since the Second World War and her role as an academic, judge and Court President; for her clear, constructive as well as innovative and groundbreaking books, writings, articles and court decisions in defence of the rule of law and human rights; for her leading role in strengthening and enlarging modern international law".

Karlheinz Stierle (member of the Heidelberger Akademie der Wissenschaften, Professor Emeritus of Romance literature at the University of Constance and Corresponding Fellow of the Acadmie des Sciences morales et politiques, Paris) justified the assignment of the Prize for European Literature (1000-1500) to Michel Zink as follows: "for his fundamental contributions to the understanding of French and Occitan literature in the Middle Ages, a decisive chapter in the development of modern European literature; for his new interpretation of the relation between medieval and modern literature; for his seminal initiatives that have brought the literature of the Middle Ages back into the cultural tradition of France and Europe".

Nicole Le Douarin (Honorary Permanent Secretary of the Acad mie des Sciences and Honorary Professor at the Collge de France) justified the assignment of the Prize for Innate Immunity jointly to Bruce Beutler and Jules Hoffmann as follows: "for their discovery of the genetic mechanisms responsible for innate immunity. They have worked in close cooperation to develop a new vision of the molecular defence strategy deployed by animals across a wide evolutionary spectrum against infectious agents. Their work has led to very promising medical applications".

Nicola Cabibbo (Professor of Physics at the University La Sapienza in Rome, Fellow of the Accademia Nazionale dei Lincei in Rome and President of the Pontifical Academy of Sciences) justified the assignment of the Prize for Nanoscience to Sumio Iijima as follows: "for his discovery of carbon nanotubes and in particular the discovery of single walled carbon nanotubes and the study of their properties".

The President of the Balzan Foundation "Prize", Ambassador Bruno Bottai motivated the assignment of the Balzan Prize for Humanity, Peace and Brotherhood among Peoples to Karlheinz Bhm as follows: "for his life's work serving humanity and peace, for his extraordinary personal commitment, for the successful, outstanding network of activities he has created to support concrete affirmative action in Ethiopia, a country with one of the most ancient cultures in the world, but one of the poorest".

The President of the General Prize Committee, Sergio Romano, added that the awarded subjects, which vary each year, make it possible to encourage specific fields of study which are new or unknown to other international awards. As usual, the Committee's 20 prestigious scholars from 11 different European countries put a great deal of effort in selecting the winners from among the candidates submitted by the most important international cultural institutions.

Ambassador Bottai, expressed satisfaction for the prestige of the eminent scholars who will receive the Balzan Prize on 23 November in Berne (in compliance with the rule of alternation between the Italian and the Swiss capitals). It is important to remember that the Balzan Foundation requests that half of the million Swiss Francs received by the winner of each of the four subjects be destined for research work, preferably involving young scholars and researchers.

The announcement, which took place at Milan's Ulrico Hoepli Civic Planetarium under the auspices of the City of Milan and with the participation of Mayor Letizia Moratti, Commissioner for Culture Vittorio Sgarbi and President of the City Council Manfredi Palmeri, was followed by a lecture by Professor Paolo de Bernardis, 2006 Balzan Prize for Observational Astrophysics and Astronomy and Professor of Astrophysics at the University La Sapienza in Rome. The lesson, titled "Archaeology of the Universe", illustrated how the analysis of cosmic microwave background radiation allows the observation of the first evolutionary stages in the Universe after the Big Bang.


'/>"/>
Contact: Susannah Gold
info@goldcommunications.net
212-222-7595
Gold Communications
Source:Eurekalert

Related biology news :

1. W.M. Keck Foundation funds study of friendly microbes
2. Digging in the dirt for lifes biochemical foundations
3. Protein folding: Building a strong foundation
4. Wiley announces publication of Databasing the Brain
5. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
6. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
7. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
8. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
9. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
10. GlycoFi announces the first production of antibodies with human glycosylation in yeast
11. NHGRI announces new sequencing targets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):
(Date:5/24/2016)... ... May 24, 2016 , ... Cell therapies for a ... accelerated by research at Worcester Polytechnic Institute (WPI) that yielded a newly patented ... regeneration. , The novel method, developed by WPI faculty members Raymond Page, PhD, ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... Last week, ... for corporate executives and entrepreneurs, held The Future of San Diego Life Science event ... San Diego life science community attended the event with speakers Dr. Rich Heyman, former ...
(Date:5/23/2016)... ... ... blood donations in South Texas and across the nation is growing. , But according to ... are on the decline. In fact, donations across the country are at their lowest point ... the last four years alone. , There is no substitute for blood. , “We want ...
(Date:5/23/2016)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of $0.24 per share ... stockholders of record as of the close of business on ... approval of the Board of Directors and may be adjusted ...
Breaking Biology Technology: